Back
Deciphera Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
78
DCPH
Deciphera Pharmaceuticals
Last Price:
25.38
Seasonality Move:
15.38%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
151.49
Seasonality Move:
23.32%
Buy
78
Deciphera Pharmaceuticals (DCPH)
is a Buy
Is Deciphera Pharmaceuticals a Buy, Sell or Hold?
- The current Deciphera Pharmaceuticals [DCPH] share price is $25.38. The Score for DCPH is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- DCPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $151.37. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DCPH Stock Price Chart
What is Deciphera Pharmaceuticals's stock price today?
-
The Deciphera Pharmaceuticals share price today is $25.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DCPH is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $151.37
The current trend is relatively stagnant and ALNY is experiencing slight selling pressure.
DCPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.82 | Buy |
| Relative Strength Index (14 RSI): | 85.89 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.63 - 23.69) | Buy |
| Bollinger Bands (100): | (13.29 - 19.23) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 53.47 | Buy |
| Chaikin Money Flow: | -78605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.97 - 152.93) | Buy |
| Bollinger Bands (100): | (146.02 - 181.8) | Sell |
DCPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.36 | Buy |
| 20-day SMA: | 19.47 | Buy |
| 50-day SMA: | 17.27 | Buy |
| 200-day SMA: | 14.6 | Buy |
| 8-day EMA: | 24.25 | Buy |
| 20-day EMA: | 21.11 | Buy |
| 50-day EMA: | 18.24 | Buy |
| 200-day EMA: | 15.58 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.7 | Buy |
| 20-day SMA: | 147.67 | Buy |
| 50-day SMA: | 149.39 | Buy |
| 200-day SMA: | 170.5 | Sell |
| 8-day EMA: | 150.78 | Buy |
| 20-day EMA: | 149.49 | Buy |
| 50-day EMA: | 152.18 | Sell |
| 200-day EMA: | 168.38 | Sell |
Deciphera Pharmaceuticals Earnings Growth & DCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.53 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Deciphera Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||